TRDA
NASDAQ HealthcareEntrada Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $12.98 |
|---|---|
| Volume | 196,361 |
| Market Cap | 496.93M |
| Beta | -0.120 |
| RSI (14-Day) | 62.6 |
| 200-Day MA | $8.19 |
| 50-Day MA | $11.25 |
| 52-Week High | $13.65 |
| 52-Week Low | $4.93 |
| Forward P/E | -3.71 |
| Price / Book | 1.53 |
🎯 Investment Strategy Scores
How TRDA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
49/100
High dividend yield + low volatility
🚀 Moon Shot
2/100
High growth potential (high beta + oversold)
🔪 Falling Knife
3/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
89/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
13/100
Large-cap, institutional-quality stocks
Find TRDA in your text
Paste any text on the homepage — the tool will extract TRDA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.